Summary. Two hybridoma cell lines that produce monoclonal antibodies against Aeromonas hydrophila haemolysin were established by fusion of myeloma and spleen cells obtained from a mouse immunised with haemolysin detoxified with tetranitromethane. Enzyme-linked immunosorbent assay (ELISA) showed that the two purified monoclonal antibodies, B7 and B1 1, recognised the same epitope on the haemolysin molecule. Antibody B7 neutralised the haemolytic and enterotoxic activities of the haemolysin. It is concluded that the same site on the haemolysin molecule is responsible for both haemolytic and enterotoxic activities.
Introduction
Aeromonas hydrophila has been implicated in human acute diarrhoea (Burke et al., 1983; Cumberbatch et al., 1979; George et al., 1985; Gracey et al., 1982; Holmberg and Farmer, 1984; Janda et al., 1984; Pitarangsi et al., 1982) . Although A . hydrophila produces several biologically-active substances, including haemolysin, cytotoxin, enterotoxin and proteolytic enzymes (Donta and Haddow, 1978; Turnbull et al., 1984; Wretlind et al., 1973) , the enterotoxic factor has not been conclusively identified. Some workers have suggested that there is a close relationship between haemolysin or cytotoxin production and enterotoxigenicity (Burke et al., 1983; Cumberbatch et al., 1979; Millership et al., 1986; Turnbull et al., 1984) . We succeeded in purifying haemolysins produced by isolates from clinical and environmental sources. Both haemolysins cause fluid accumulation in the infant mouse intestine and rabbit ileal loop and have a cytotoxic effect on Vero cells, which suggests that the haemolysins are cytotoxic enterotoxins (Asao et al., 1984 (Asao et al., ,1986 . It remains to be shown at the molecular level, however, that the alterations in erythrocytes caused by the haemolysin are the same as those in the gut.
This report describes the production of monoclonal antibodies against A . hydrophila haemolysin and their use to identify the site on the haemolysin The haemolysin of A . hydrophila strain CA-1 1, isolated from an environmental source, was purified by the method described earlier (Asao et al., 1986) and antiserum against the haemolysin was obtained from a rabbit (Asao et al., 1986) . The haemolysin was detoxified by treating with tetranitromethane (Aldrich) by a slight modification of the method of Cuatrecasas et al. (1 968) . To a haemolysin solution (340 pg/ml) in 0.05 M Tris-HC1 buffer, pH 7.5, containing 1 M urea, a one-tenth volume of tetranitromethane 10% in ethyl alcohol was added. After incubation for 1 h at room temperature, the mixture was applied to a PD-10 column (Pharmacia) equilibrated with 0-05 M Tris-HC1 buffer, pH 7.5, containing 1 M urea, to remove excess tetranitromethane. Protein content was determined by the method of Lowry et al. (1951) . The haemolytic activity and mouse lethal toxicity of tetranitromethane-treated haemolysin were assayed by the methods previously described (Asao et al., 1984) .
Production of hybridoma cell lines
Eight-week-old male BALB/c mice were primed intraperitoneally with the toxoid (10 pg in 0.15 ml) emulsified in the same volume of Freund's complete adjuvant (Difco). A booster injection of the toxoid (10 pg in 0.15 ml) in Freund's incomplete adjuvant (Difco) was given intraperitoneally after one week. After 3 weeks, S . KOZAKI ET AL. similar third and fourth booster injections were given. A final injection was given intravenously without adjuvant after a further 4 days. The fusion was performed 3 days later. Spleen cells (lo8) were fused with myeloma cells (2 x lo', Sp2/0-Ag14) with 50% polyethylene glycol (mol. wt 4000; Merck) and the resulting hybridomas were cloned by the limit dilution method. After transplantation of the hybridoma cells into the peritoneal cavities of BALB/c mice primed with pristane (Aldrich), ascitic fluid containing monoclonal antibody was obtained. The monoclonal antibody was purified by Affi-gel Protein A (Bio-Rad) chromatography. Agar gel diffusion tests were carried out with anti-mouse immunoglobulin G (IgG; Sigma) to determine the subclass of each monoclonal antibody. The light chain of the monoclonal antibody was identified by enzyme-linked immunosorbent assay (ELISA) with anti-mouse K and A chains (Nordic).
ELISA for detecting monoclonal antibody
The wells of flat-bottomed microtitration plates (Dynatech) each received 0.1 ml of haemolysin (0.5 pg/ml) in 0.1 M sodium carbonate-bicarbonate buffer, pH 9.6. After 3 h at 37"C, the wells were washed once with 0.01 M phosphate buffer, pH 7.2, containing 0.15 M NaCl and Tween 20 0.05% (PBS-Tween). Each well then received 0.2ml of PBS-l% gamma globulin-free horse serum (Gibco). After incubation overnight at 4"C, the wells were again washed with PBS-Tween. A sample, 0.1 ml of culture supernate or purified monoclonal antibody, was added to each. After 2 h at 37"C, the wells were washed, and 0.1 ml of rabbit anti-mouse IgG conjugated with peroxidase (Cooper Biochemical) was added to each. After 2 h at 37°C and the final washing, 0.15 ml of a substrate solution (0.04% o-phenylenediamine in 0.05 M citric acid-0.1 M Na2HP04, pH 5.0, plus H 2 0 2 0.006%) was added. After incubation for 30min at 37"C, the reaction product was measured at 492 nm with a BioRad Model 2550 EIA reader. Epitope specificities of the peroxidase-conjugated monoclonal antibodies were also determined by ELISA. Each monoclonal antibody was conjugated with peroxidase by the method of Nakane and Kawaoi (1 974). After the conjugated monoclonal antibodies had been mixed with unconjugated homologous or heterologous monoclonal antibodies, ELISA was performed as described above.
Titration of monoclonal antibodies for neutralising activities
A haemolysin solution (80 ng/ml) was mixed with an equal volume of a monoclonal antibody diluted serially with 0.01 M Tris-HC1 buffer, pH 7.2, containing NaCl 0.9% (TBS). After incubation for 1 h at 37"C, the remaining haemolytic activity was determined with rabbit erythrocytes at 25°C (Asao et al., 1986) . To titrate the monoclonal antibody for neutralisation of the haemolysin-induced fluid accumulation in the infant mouse, each monoclonal antibody diluted with TBS was incubated with a one-tenth volume of haemolysin (22 pg/ml) for 1 h at 37°C. The mixture (0.1 ml) was given intragastrically to a 4-5-day-old mouse. After 4 h at 25"C, the mice were killed with chloroform. The ratio of the intestinal weight to the remaining body weight (FA ratio) was measured by the method of Dean et al. (1972) .
Results
After treatment with tetranitromethane, the haemolysin retained only 1% or less of its original haemolytic activity and mouse lethal toxicity. Agar gel diffusion tests showed identical precipitin lines of haemolysin before and after treatment with tetranitromethane when diffused against anti-haemolysin serum. Two cell lines (B7 and Bll) were established from hybridomas of the spleen cells obtained from the haemolysin-immunised mouse and myeloma cells. The monoclonal antibodies purified from the ascitic fluid contained K light chain and were of IgG, isotype. In ELISA the two monoclonal antibodies showed high reactivities with the haemolysin ( fig. 1 ) and by competitive ELISA they were found to recognise the same epitope on the haemolysin molecule. Monoclonal antibody B7 effectively neutralised the haemolytic activity at a relatively low concentration ( fig. 2) . One or two molecules of B7 per haemolysin molecule caused 50% inactivation of the haemolytic activity of the haemolysin. In the infant mouse test, B7 was found also to neutralise the enterotoxic activity of the haemolysin (table) . The neutralising potency of B7 for the enterotoxic activity was almost equivalent to that for the haemolytic activity.
Discussion
Several investigators have attempted to correlate the haemolytic activity with the enterotoxic activity produced by A . hydrophila Stelma et al., 1986; Turnbull et al., 1984) . The purified haemolysin was cytotoxic for cultured cells and caused fluid accumulation in the infant mouse and rabbit ileal loop (Asao et al., 1984 (Asao et al., , 1986 Bunning et al., 1986; Stelma et al., 1986) . Even though such evidence has been accumulated, the haemolysin is not unanimously accepted as an enteropathogenic factor because there is no convincing evidence to show that the haemolytic and enterotoxic activities are elicited by the same site on the haemolysin molecule.
We, therefore, prepared monoclonal antibodies against the haemolysin to examine their neutralising activities for the haemolytic and enterotoxic activities. The native haemolysin was inadequate The mixtures of haemolysin 2 pg/mi and antibody at the above concentrations were given as 0.1 -ml doses to infant mice.
* Considered positive if the ratio was higher than 0.09 (Dean et al., 1972) .
as the immunogen because of its mouse lethality but when treated with formalin it formed undesirable aggregates. Formalinisation was thus not suitable for detoxifying the haemolysin (unpublished data). Although the treatment with tetra; nitromethane resulted in only incomplete 
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two monoclonal antibodies were found to be the same by competitive ELISA. One of the two monoclonal antibodies, B7, neutralised both the haemolytic and enterotoxic activities of the haemolysin. Furthermore, about one molecule of the monoclonal antibody was enough to suppress completely the activities of the haemolysin molecule. These observations strongly indicate that the
